KEY FEATURES
| Full Name | Kruppel Like Factor 4, Gut |
|---|---|
| Synonym | EZF; GKLF; Gut-Enriched Krüppel-Like Factor; Epithelial zinc finger protein EZF |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.15-10ng/mL |
| Sensitivity | 0.06ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human KLF4 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human KLF4. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human KLF4 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human KLF4, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human KLF4. You can calculate the concentration of Human KLF4 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human KLF4 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.49 | 0.84 | 3.79 | 0.53 | 0.82 | 3.77 |
| Standard deviation | 0.03 | 0.04 | 0.2 | 0.04 | 0.05 | 0.12 |
| CV(%) | 6.17 | 4.75 | 5.36 | 6.86 | 5.81 | 3.1 |
RECOVERY
The recovery of Human KLF4 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 84-100 | 91 |
| EDTA plasma (n=8) | 90-100 | 95 |
| Cell culture media (n=8) | 95-111 | 102 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human KLF4 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with KLF4 ELISA Kits
| SP1 ELISA Kit | publications with KLF4 and SP1 |
| CTNNB1 ELISA Kit | publications with KLF4 and CTNNB1 |
| TGFB1 ELISA Kit | publications with KLF4 and TGFB1 |
| TP53 ELISA Kit | publications with KLF4 and TP53 |
| HDAC2 ELISA Kit | publications with KLF4 and HDAC2 |
| RELA ELISA Kit | publications with KLF4 and RELA |
| KAT5 ELISA Kit | publications with KLF4 and KAT5 |
| EP300 ELISA Kit | publications with KLF4 and EP300 |
| CREBBP ELISA Kit | publications with KLF4 and CREBBP |
Pathways associated with KLF4 ELISA Kit
| Developmental Biology Pathway | Developmental Biology Pathway |
| Metabolism Of Proteins Pathway | Metabolism Of Proteins Pathway |
| Peptide Hormone Metabolism Pathway | Peptide Hormone Metabolism Pathway |
| Regulation Of Wnt-mediated Beta Catenin Signaling And Target Gene Transcription Pathway | Regulation Of Wnt-mediated Beta Catenin Signaling And Target Gene Transcription Pathway |
| SRF And MiRs In Smooth Muscle Differentiation And Proliferation Pathway | SRF And MiRs In Smooth Muscle Differentiation And Proliferation Pathway |
| Signaling Pathways Regulating Pluripotency Of Stem Cells | Signaling Pathways Regulating Pluripotency Of Stem Cells |
| Synthesis, Secretion, And Deacylation Of Ghrelin Pathway | Synthesis, Secretion, And Deacylation Of Ghrelin Pathway |
| Transcriptional Regulation Of Pluripotent Stem Cells Pathway | Transcriptional Regulation Of Pluripotent Stem Cells Pathway |
| Transcriptional Regulation Of White Adipocyte Differentiation Pathway | Transcriptional Regulation Of White Adipocyte Differentiation Pathway |
Diseases associated with KLF4 ELISA Kit
| Cardiovascular Diseases | publications with KLF4 and Cardiovascular Diseases |
| Nervous System Diseases | publications with KLF4 and Nervous System Diseases |
| Disease Models, Animal | publications with KLF4 and Disease Models, Animal |
| Inflammation | publications with KLF4 and Inflammation |
| Breast Neoplasms | publications with KLF4 and Breast Neoplasms |
| Heart Diseases | publications with KLF4 and Heart Diseases |
| Carcinoma, Squamous Cell | publications with KLF4 and Carcinoma, Squamous Cell |
| Neoplasms, Experimental | publications with KLF4 and Neoplasms, Experimental |
| Lung Diseases | publications with KLF4 and Lung Diseases |
| Hyperplasia | publications with KLF4 and Hyperplasia |
Organs/Tissues associated with KLF4 ELISA Kit
| Embryonic Tissue | publications with KLF4 and Embryonic Tissue |
| Skin | publications with KLF4 and Skin |
| Vascular | publications with KLF4 and Vascular |
| Heart | publications with KLF4 and Heart |
| Brain | publications with KLF4 and Brain |
| Liver | publications with KLF4 and Liver |
| Lung | publications with KLF4 and Lung |
| Intestine | publications with KLF4 and Intestine |
| Eye | publications with KLF4 and Eye |
| Kidney | publications with KLF4 and Kidney |